| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| ln Vitro |
In the striatal membrane of WT mice, GPR88 agonist 2 markedly increased [35S]GTPγS binding activity (EC50: 8.9 μM), whereas in the striatal membrane of GPR88 KO mice, GPR88 agonist 2 was inert [1].
|
|---|---|
| ln Vivo |
Good plasma exposure (Cmax: 1670 ng/mL) and reasonable metabolic stability (T1/2: 4.66h, CL: 21 mL/mg/kg) are features of GPR88 agonist 2 (20 mg/ml, i.p.)[1]. The intraperitoneal injection of GPR88 agonist 2 (20 mg/ml) exhibits adequate brain penetration (Cmax: 576 ng/mL) [1]. Ratio plasma 1670 5.6 21 0.34 brain 576 / /, ip Cmax (ng/mL), T1/2 (h), CL(mL/min/kg), and B/Pratio 20 mg/kg
|
| References |
| Molecular Formula |
C26H33N5O3
|
|---|---|
| Molecular Weight |
463.571925878525
|
| Exact Mass |
463.258
|
| CAS # |
2821859-71-4
|
| PubChem CID |
168679882
|
| Appearance |
Off-white to light yellow solid powder
|
| LogP |
3.9
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
11
|
| Heavy Atom Count |
34
|
| Complexity |
634
|
| Defined Atom Stereocenter Count |
3
|
| SMILES |
CC[C@H](C)COC1=CC=C(C=C1)[C@H](CN2C=C(N=N2)C(=O)NC)NC(=O)[C@@H](C)C3=CC=CC=C3
|
| InChi Key |
LVUMROGMIIBKQA-YDHSSHFGSA-N
|
| InChi Code |
InChI=1S/C26H33N5O3/c1-5-18(2)17-34-22-13-11-21(12-14-22)23(15-31-16-24(29-30-31)26(33)27-4)28-25(32)19(3)20-9-7-6-8-10-20/h6-14,16,18-19,23H,5,15,17H2,1-4H3,(H,27,33)(H,28,32)/t18-,19-,23-/m0/s1
|
| Chemical Name |
N-methyl-1-[(2R)-2-[4-[(2S)-2-methylbutoxy]phenyl]-2-[[(2S)-2-phenylpropanoyl]amino]ethyl]triazole-4-carboxamide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (5.39 mM) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), Clear solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of corn oil and mix well. (Please use freshly prepared in vivo formulations for optimal results.) |
|---|
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1572 mL | 10.7859 mL | 21.5717 mL | |
| 5 mM | 0.4314 mL | 2.1572 mL | 4.3143 mL | |
| 10 mM | 0.2157 mL | 1.0786 mL | 2.1572 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
